Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Pharmaceuticals Inc.

Division of Mylan NV
www.mylanpharms.com

Latest From Mylan Pharmaceuticals Inc.

Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents

District court questions legitimacy of Allergan's patent transfer tactic, saying it 'could spell the end of the PTO's IPR program.'

Intellectual Property Legal Issues

Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents

District court questions legitimacy of Allergan's patent transfer tactic, saying it 'could spell the end of the PTO's IPR program.'

Intellectual Property Policy

CHMP Readies ‘Outstanding Issues’ Lists For Products Nearing EU Review End

Baxter, Ariad, Diurnal. Kyowa Kirin and AB Science are among the companies that will shortly find out what remaining concerns the European Medicines Agency’s key advisory panel, the CHMP, has regarding products of theirs that are under review.

Europe Approvals

Europe Too: Approval Of A Higher Dose Glatiramer Generic

Like in the US, Teva's more convenient three-times-a-week dosage form of Copaxone is now facing competition in Europe from a generic, in this case one developed by the Netherlands' Synthon and Iceland's Alvogen.

Approvals Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • Hal Korman, Pres.
  • Contact Info
  • Mylan Pharmaceuticals Inc.
    Phone: (304) 599-2595
    781 Chestnut Ridge Rd.
    P.O. Box 4310 Morgantown, WV 26505
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register